The 2014 Big Data in Biomedicine conference was held here last month, and keynote speakers, panelists, moderators and attendees are now available on the Stanford Medicine YouTube channel. To continue the discussion of how big data can be harnessed to benefit human health, we’ll be featuring a selection of the videos this month on Scope.
Ann Wojcicki, CEO and co-founder of personal-genetics company 23andMe, delivered a keynote speech at Big Data in Biomedicine in 2013 about empowering patients and the importance of owning one’s genetic data. Returning this year to the conference as an attendee, Wojcicki spoke in a Behind the Scenes at Big Data interview about, among other things, her early interest in genes, her belief that genetics are an important part of preventative care, and her desire for a framework where patient communities can easily participate, and potentially direct, medical research. She also discussed the status of 23andMe in the U.S. Food and Drug Administration authorization process and sounded a hopeful note about patients’ future access to their genetic information. “I believe that in the next 10 years everyone will have their genome,” she said.